Claims
- 1. A dialysis solution including an osmotic agent comprising a water soluble polyglycol having molecular weight from about 500 to 20,000 daltons.
- 2. The dialysis solution of claim 2 wherein the osmotic agent has a molecular weight of from about 3,000 to about 5,000 daltons.
- 3. The dialysis solution of claim 1 wherein the osmotic agent comprises a linear polymer containing repeating units represented by —(CH2CH2O)—.
- 4. The dialysis solution of claim 3 wherein the osmotic agent comprises polyethylene glycol.
- 5. The dialysis solution of claim 4 wherein the osmotic agent comprises polyethylene glycol having a molecular weight of about 3350.
- 6. The dialysis solution of claim 4 wherein the osmotic agent is polyethylene glycol having a molecular weight of about 4,000.
- 7. The dialysis solution of claim 1 wherein the osmotic agent comprises a branched polymer containing repeating units represented by —(CH2CH2O)—.
- 8. The dialysis solution of claim 7 wherein the osmotic agent comprises a branched polymer containing multiple branches including repeating units represented by —(CH2CH2O)—.
- 9. The dialysis solution of claim 1 comprising a free radical scavenger.
- 10. The dialysis solution of claim 9 wherein the free radical scavenger comprises serum albumin.
- 11. The dialysis solution of claim 9 wherein the free radical scavenger is selected from at least one of: salicylic acid, Fe(II) phenantholine, dihydroxybenzoic acid, human senrum albumin, glutathione, cysteine, ascorbic acid, benzyl alcohol, BHT, and citric acid.
- 12. The dialysis solution of claim 1 comprising from about 0.05 mole to about 1.0 mole of osmotic agent.
- 13. The dialysis solution of claim 9 comprising from about 0.2 to about 0.5 mole of osmotic agent.
- 14. A method for performing dialysis utilizing the dialysis solution of claim 1.
- 15. The method of claim 14 wherein the dialysis solution is infused into the peritoneum.
- 16. A method of claim 14 wherein a filter is used in-line to prevent bacteria to enter the peritoneal cavity.
- 17. A method of claim 16 wherein the filter has pores of about 0.2 microns.
- 18. The treatment of claim 14 wherein the dialysis solution is used for hemodialysis by contacting a patient's blood with a semipermeable membrane wherein water and waste products flow from the blood, through the membrane and into the dialysis solution.
- 19. A dialysis solution comprising a free radical scavenger.
- 20. The dialysis solution of claim 19 wherein the free radical scavenger is selected form at least one of: salicylic acid, Fe(II) phenantholine, dihydroxybenzoic acid, human serum albumin, glutathione, cysteine, ascorbic acid, benzyl alcohol, BHT, and citric acid.
CROSS-REFERENCE TO RELATED APPLICATION
[0001] This application is a continuation-in-part of U.S. patent application Ser. No. 09/687,512 filed Oct. 13, 2006, which claims the benefit of U.S. Provisional Application No. 60/159,810, filed Oct. 15, 1999.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60159810 |
Oct 1999 |
US |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
09687512 |
Oct 2000 |
US |
Child |
10396671 |
Mar 2003 |
US |